VolitionRx Limited Retained Earnings
VolitionRx Limited (VNRX) had Retained Earnings of -$267.35 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$267.35M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$259.57M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$252.90M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$246.63M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$267.35M 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$259.57M 10-Q · filed 2026-05-14 |
| 2025-12-31 | -$252.90M 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$246.63M 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$241.25M 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$234.97M 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$229.54M 10-K · filed 2026-03-31 |
| 2024-09-30 | -$223.75M 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$217.93M 10-Q · filed 2024-08-14 |
| 2024-03-31 | -$210.94M 10-Q · filed 2024-05-13 |
| 2023-12-31 | -$202.58M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$193.88M 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$185.51M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$176.04M 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$167.26M 10-K · filed 2024-03-25 |
| 2022-09-30 | -$160.02M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$152.27M 10-Q · filed 2022-08-10 |
| 2022-03-31 | -$144.62M 10-Q · filed 2022-05-11 |
| 2021-12-31 | -$136.99M 10-K · filed 2023-03-15 |
| 2021-09-30 | -$128.95M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$121.82M 10-Q · filed 2021-08-11 |
| 2021-03-31 | -$116.29M 10-Q · filed 2021-05-11 |
| 2020-12-31 | -$110.17M 10-K · filed 2022-03-30 |
| 2020-09-30 | -$105.04M 10-Q · filed 2020-11-12 |
| 2020-06-30 | -$100.71M 10-Q · filed 2020-08-13 |
| 2020-03-31 | -$95.68M 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$89.82M 10-K · filed 2021-03-22 |
| 2019-09-30 | -$86.26M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$82.08M 10-Q · filed 2019-08-12 |
| 2019-03-31 | -$77.93M 10-Q · filed 2019-05-08 |
| 2018-12-31 | -$73.72M 10-K · filed 2020-02-20 |
| 2018-09-30 | -$69.44M 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$64.96M 10-Q · filed 2018-08-13 |
| 2018-03-31 | -$60.37M 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$55.71M 10-K · filed 2019-03-13 |
| 2017-09-30 | -$51.65M 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$47.76M 10-Q · filed 2017-08-10 |
| 2017-03-31 | -$44.30M 10-Q · filed 2017-05-11 |
| 2016-12-31 | -$40.94M 10-K · filed 2018-03-01 |
| 2016-09-30 | -$37.96M 10-Q · filed 2016-11-10 |
| 2016-06-30 | -$34.48M 10-Q · filed 2016-08-11 |
| 2016-03-31 | -$31.53M 10-Q · filed 2016-05-13 |
| 2015-12-31 | -$29.04M 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |